Immediate Impact
8 standout
Citing Papers
Immune-related adverse events of immune checkpoint inhibitors: a review
2023 Standout
Acute myeloid leukaemia
2023 Standout
Works of Joel Wight being referenced
Immune priming with avelumab and rituximab prior to R-CHOP in diffuse large B-cell lymphoma: the phase II AvR-CHOP study
2023
Utility of clinical comprehensive genomic characterization for diagnostic categorization in patients presenting with hypocellular bone marrow failure syndromes
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Joel Wight | 41 | 100 | 54 | 21 | 152 | |
| Michela Ansuinelli | 24 | 87 | 60 | 13 | 135 | |
| Mahsa Khanlari | 61 | 87 | 106 | 28 | 181 | |
| Paolo Avanzini | 39 | 129 | 76 | 24 | 173 | |
| Lavinia Grapulin | 21 | 62 | 67 | 17 | 143 | |
| Claudia Mannu | 66 | 147 | 111 | 19 | 206 | |
| Rabea Wagener | 32 | 59 | 33 | 26 | 218 | |
| Bernard De Prijck | 104 | 94 | 64 | 24 | 223 | |
| Renata Woroniecka | 117 | 173 | 107 | 27 | 226 | |
| Lianna J. Marks | 23 | 39 | 36 | 20 | 129 | |
| Iván Murrieta-Álvarez | 20 | 72 | 35 | 32 | 161 |
All Works
Login with ORCID to disown or claim papers
Loading papers...